Developmental Alterations in the DTI-ALPS Index Suggest Possible Glymphatic-Related Mechanisms Underlying Excitation/Inhibition Imbalance and Psychosis Vulnerability in 22q11.2 Deletion Syndrome

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Biological Psychiatry Global Open Science

• Publication date

  2026-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.bpsgos.2026.100713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The change of MRI indexes of brain glymphatic function and sleep status before and after repeated transcranial magnetic stimulation in insomnia disorder patients

  2025cited by this paper
• Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases—an update

  2025cited by this paper
• Age-related change of glymphatic function in normative children assessed using diffusion tensor imaging-analysis along the perivascular space.

  2025cited by this paper
• Assessing neonatal brain glymphatic system development using diffusion tensor imaging along the perivascular space and choroid plexus volume

  2025cited by this paper
• Enhancement of glymphatic function and cognition in chronic insomnia using low-frequency rTMS.

  2025cited by this paper
• Glymphatic system: a self-purification circulation in brain

  2025cited by this paper
• Prevalence of Parkinson's Disease in 22q11.2 Deletion Syndrome: A Multicenter Study

  2025cited by this paper
• Assessment of glymphatic function and white matter integrity in children with autism using multi-parametric MRI and machine learning

  2025cited by this paper
• Combining phenomics with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion

  2025cited by this paper
• Vortioxetine Improves Brain Glymphatic System Function, Functional Connectivity, and Cognitive Functions in Major Depressive Disorder

  2025cited by this paper
• Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories.

  2025cited by this paper
• Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): Revisiting the Meaning and Significance of the Method

  2024cited by this paper
• Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants.

  2024cited by this paper
• Glymphatic system dysfunction in neurodegenerative diseases

  2024cited by this paper
• The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle.

  2024cited by this paper
• Glymphatic imaging: a critical look at the DTI-ALPS index

  2024cited by this paper
• Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep.

  2024cited by this paper
• Diffusion tensor imaging along the perivascular space: the bias from crossing fibres

  2024cited by this paper
• Effects of sleep on the glymphatic functioning and multimodal human brain network affecting memory in older adults

  2024cited by this paper
• Glymphatic influx and clearance are perturbed in Huntington’s disease

  2024cited by this paper
• Diffusion Tensor Imaging‐Along the Perivascular‐Space Index Is Associated with Disease Progression in Parkinson's Disease

  2024cited by this paper
• Excitation/inhibition imbalance in schizophrenia: a meta-analysis of inhibitory and excitatory TMS-EMG paradigms

  2024cited by this paper
• The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

  2024cited by this paper
• Evaluation of the Glymphatic System in Schizophrenia Spectrum Disorder Using Proton Magnetic Resonance Spectroscopy Measurement of Brain Macromolecule and Diffusion Tensor Image Analysis Along the Perivascular Space Index.

  2024cited by this paper
• Glymphatic System Dysfunction Underlying Schizophrenia Is Associated With Cognitive Impairment.

  2024cited by this paper
• 22q11.2 Deletion-Associated Blood-Brain Barrier Permeability Potentiates Systemic Capillary Leak Syndrome Neurologic Features

  2024cited by this paper
• The glymphatic system’s role in traumatic brain injury-related neurodegeneration

  2023cited by this paper
• The CLDN5 gene at the blood-brain barrier in health and disease

  2023cited by this paper
• Hippocampal Vascular Supply and Its Role in Vascular Cognitive Impairment

  2023cited by this paper
• Amygdala subdivisions exhibit aberrant whole-brain functional connectivity in relation to stress intolerance and psychotic symptoms in 22q11.2DS

  2023cited by this paper
• Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders.

  2023cited by this paper
• Glymphatic Imaging in Pediatrics

  2023cited by this paper
• Glymphatic system impairment in sleep disruption: diffusion tensor image analysis along the perivascular space (DTI-ALPS)

  2023cited by this paper
• Diffusion-weighted image analysis along the perivascular space (DWI–ALPS) for evaluating interstitial fluid status: age dependence in normal subjects

  2022cited by this paper
• Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration

  2022cited by this paper
• Synaptic Plasticity Dysfunctions in the Pathophysiology of 22q11 Deletion Syndrome: Is There a Role for Astrocytes?

  2022cited by this paper
• Children with autism spectrum disorder present glymphatic system dysfunction evidenced by diffusion tensor imaging along the perivascular space

  2022cited by this paper
• Improved reproducibility of diffusion tensor image analysis along the perivascular space (DTI-ALPS) index: an analysis of reorientation technique of the OASIS-3 dataset

  2022cited by this paper
• Glymphatic Dysfunction Induced Oxidative Stress and Neuro-Inflammation in Major Depression Disorders

  2022cited by this paper
• The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis

  2022cited by this paper
• Excitatory inhibitory imbalance underlies hippocampal atrophy in individuals with 22q11.2 Deletion Syndrome with psychotic symptoms

  2022cited by this paper
• The glymphatic system: Current understanding and modeling

  2022cited by this paper
• Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis.

  2021cited by this paper
• Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders

  2021cited by this paper
• Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions

  2021cited by this paper
• Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood–Brain Barrier Model

  2021cited by this paper
• Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

  2021cited by this paper
• 22q11.2 deletion syndrome and schizophrenia.

  2020cited by this paper
• Effect of Age on GABA+ and Glutathione in a Pediatric Sample

  2020cited by this paper
• Role of Astrocyte Dysfunctions in 22q11 Deletion Syndrome

  2020cited by this paper
• Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice

  2020cited by this paper
• In vivo evidence of microstructural hypo-connectivity of brain white matter in 22q11.2 deletion syndrome

  2020cited by this paper
• The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation

  2020cited by this paper
• Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis

  2020cited by this paper
• Abnormal Development and Dysconnectivity of Distinct Thalamic Nuclei in Patients With 22q11.2 Deletion Syndrome Experiencing Auditory Hallucinations.

  2020cited by this paper
• Mitochondrial Dysfunction Leads to Cortical Under-Connectivity and Cognitive Impairment.

  2019cited by this paper
• Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.

  2019cited by this paper
• Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS

  2019cited by this paper
• Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study

  2019cited by this paper
• Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia

  2018cited by this paper
• The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system?

  2018cited by this paper
• Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis

  2018cited by this paper
• Genetic insights into the neurodevelopmental origins of schizophrenia

  2017cited by this paper
• Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases

  2017cited by this paper
• The immune deficiency of chromosome 22q11.2 deletion syndrome

  2017cited by this paper
• Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

  2017cited by this paper
• Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study

  2017cited by this paper
• Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review

  2016cited by this paper
• Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.

  2016cited by this paper
• Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

  2016cited by this paper
• Large-scale functional network reorganization in 22q11.2 deletion syndrome revealed by modularity analysis.

  2016cited by this paper
• Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome

  2016cited by this paper
• The Glymphatic System: A Beginner’s Guide

  2015cited by this paper
• 22q11.2 deletion syndrome

  2015cited by this paper
• Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

  2014cited by this paper
• Glutamate-mediated excitotoxicity in schizophrenia: a review.

  2014cited by this paper
• Identifying 22q11.2 Deletion Syndrome and Psychosis Using Resting-State Connectivity Patterns

  2014cited by this paper
• Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

  2014cited by this paper
• Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

  2013cited by this paper
• Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.

  2013cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• Immunological aspects of 22q11.2 deletion syndrome

  2011cited by this paper
• Magnetic Resonance Spectroscopy Identifies Neural Progenitor Cells in the Live Human Brain

  2007cited by this paper
• Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization

  2006cited by this paper
• Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia

  2006cited by this paper
• The CLDN5 locus may be involved in the vulnerability to schizophrenia

  2004cited by this paper
• Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

  2001cited by this paper
• High rates of schizophrenia in adults with velo-cardio-facial syndrome.

  1999cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper

• No citing papers are available for this paper.